Drugs like Ozempic, Mounjaro and Saxenda have swept the globe since emerging on the market late last decade, and an estimated 20,000 Australians currently use the drugs for weight loss.

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Saxenda (liraglutide) is a GLP-1 that increases feelings of fullness while decreasing feelings of hunger. It has FDA approval for weight loss, unlike Ozempic, which only has approval for type 2 ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

Find out all you need to know about Ozempic and other weight loss drugs, including the dangers and side effects ...

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

Looking for weight loss options? GLP-1 agonist medications ... and fatigue. Refer to the Saxenda medication guide for full details. Reduces A1C levels by 1.9% to 2.2% over 40 weeks.

A new study conducted by researchers from the University of Eastern Finland the Karolinska Institutet explored the ways that ...

If that person loses 20 kilograms (44 pounds) in one year while taking a GLP-1R agonist — which is not unreasonable while ...

Some patients have experienced critical shifts in blood sodium levels.

Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

Hers shares information about the average weight for women in the U.S., what women believe the ideal weight is, and the ...